|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/00 | |||
| A61P 35/04 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3044235 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14761904.3 |
| Europos patento paraiškos padavimo data | 2014-09-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-07-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/069451 |
| Data | 2014-09-11 |
| (87) | Numeris | WO 2015/036511 |
| Data | 2015-03-19 |
| (30) | Numeris | Data | Šalis |
| 13184120 | 2013-09-12 | EP |
| (72) |
HERTING, Frank, DE
RIES, Carola, DE
WARTHA, Katharina, DE
HOVES, Sabine, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND ANTIBODIES AGAINST HUMAN PD-L1 |
| COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND ANTIBODIES AGAINST HUMAN PD-L1 |